Sterling Biotech Limited reported audited earnings results for the year ended March 31, 2018. For the period, the company's revenue from operations was INR 3,597.274 million compared to INR 4,001.895 million for the same period a year ago. Total income was INR 3,652.280 million compared to INR 4,041.664 million for the same period a year ago. Loss for the period was INR 10,053.851 million compared to INR 4,124.550 million for the same period a year ago. Basic loss per equity share face value of INR 1 each was INR 36.94 compared to INR 15.15 for the same period a year ago.